AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25767372 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin (20 mg/day) + valsartan (160 mg/day)
Number of subjects: 30
Study 23859304 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan impregnated 2‐0 polydioxanone loop suture
Number of subjects: 856
Study 23859304 — intervention group
Group type: COMPARATOR
Intervention: 2‐0 polydioxanone loop suture
Number of subjects: 856
Study 21946400 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 63
Study 21946400 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy
Number of subjects: 63
Study 21946400 — intervention group
Group type: COMPARATOR
Intervention: Sham laser therapy
Number of subjects: 63
Study 18441375 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline plus nicotine replacement therapy
Number of subjects: 901
Study 18441375 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus nicotine replacement therapy
Number of subjects: 901
Study 18441375 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 901
Study 17160302 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Vacuum Aspiration (MVA)
Number of subjects: 50
Study 17160302 — intervention group
Group type: COMPARATOR
Intervention: D&C (Dilation and Curettage)
Number of subjects: 50
Study 14527864 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages matched to an individual's NFC
Number of subjects: 602
Study 14527864 — intervention group
Group type: COMPARATOR
Intervention: Messages mismatched to an individual's NFC
Number of subjects: 602
Study 14527864 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored pamphlet
Number of subjects: 602
Study 11431228 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 34
Study 11431228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 9731682 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced air warming system (n = 32)
Number of subjects: 64
Study 9731682 — intervention group
Group type: COMPARATOR
Intervention: Warmed blanket group (n = 32)
Number of subjects: 64
Study 7868440 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-support ventilation (PSV) levels from 0 to 15 cmH2O
Number of subjects: 7
Study 2923005 — intervention group
Group type: EXPERIMENTAL
Intervention: High-potency marijuana cigarette
Number of subjects: 0
Study 2923005 — intervention group
Group type: COMPARATOR
Intervention: Placebo marijuana cigarette
Number of subjects: 0
Study 2923005 — intervention group
Group type: COMPARATOR
Intervention: Control group (resting conditions)
Number of subjects: 0
Study 31779535 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Dot intervention
Number of subjects: 10
Study 29211671 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacomechanical thrombolysis
Number of subjects: 692
Study 29211671 — intervention group
Group type: COMPARATOR
Intervention: Control (anticoagulation alone)
Number of subjects: 692
Study 25749306 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline-Morphine Combination
Number of subjects: 52
Study 25749306 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 52
Study 25749306 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 52
Study 23701004 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based hearing protection training program
Number of subjects: 0
Study 23701004 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 21085983 — intervention group
Group type: EXPERIMENTAL
Intervention: Walk-run transition speed (WRTS) determination protocol
Number of subjects: 12
Study 21085983 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardio-respiratory responses at WRTS
Number of subjects: 12
Study 21085983 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived exertion (PE)
Number of subjects: 12
Study 21085983 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyographic (EMG) variables
Number of subjects: 12
Study 21085983 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear regression between EMG series and VO(2) data
Number of subjects: 12
Study 19929666 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous infiltration of local anaesthetic
Number of subjects: 32
Study 19929666 — intervention group
Group type: COMPARATOR
Intervention: Regional nerve block
Number of subjects: 32
Study 17180619 — intervention group
Group type: EXPERIMENTAL
Intervention: L: ‐tryptophan (Trp)
Number of subjects: 8
Study 17180619 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Plac)
Number of subjects: 8
Study 14982243 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.5 mg/kg)
Number of subjects: 14
Study 14982243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 11172150 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 Gy radiation
Number of subjects: 181
Study 11172150 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 Gy radiation
Number of subjects: 181
Study 11172150 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 Gy radiation
Number of subjects: 181
Study 11172150 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 Gy radiation
Number of subjects: 181
Study 11172150 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty alone
Number of subjects: 181
Study 9644320 — intervention group
Group type: EXPERIMENTAL
Intervention: TAT-59 (miproxifene phosphate) 20 mg orally for over 12 weeks
Number of subjects: 195
Study 9644320 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen citrate (TAM) 20 mg orally for over 12 weeks
Number of subjects: 195
Study 9644320 — intervention group
Group type: EXPERIMENTAL
Intervention: TAT-59
Number of subjects: 195
Study 9644320 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen citrate (TAM)
Number of subjects: 195
Study 8159440 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemia (blood glucose elevated to 12 mmol/l for 0.5 h and kept at that level for 2.5 h)
Number of subjects: 10
Study 8159440 — intervention group
Group type: COMPARATOR
Intervention: Euglycemia (blood glucose kept at 6 mmol/l for 3 h)
Number of subjects: 10
Study 30832575 — intervention group
Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home (FECH) program
Number of subjects: 141
Study 30832575 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 141
Study 30256811 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose vitamin D (10,000 IU/day)
Number of subjects: 51
Study 30256811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 30256811 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose vitamin D (10,000 IU/day) in younger participants (ages 52-66)
Number of subjects: 51
Study 27178513 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone (ITD) plus high dosage of betahistine (HDBH)
Number of subjects: 66
Study 27178513 — intervention group
Group type: COMPARATOR
Intervention: Intratympanic dexamethasone (ITD) plus placebo
Number of subjects: 66
Study 24231759 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Advanced Life Support reconstructed
Number of subjects: 40
Study 24231759 — intervention group
Group type: COMPARATOR
Intervention: Standard Pediatric Advanced Life Support
Number of subjects: 40
Study 22430270 — intervention group
Group type: EXPERIMENTAL
Intervention: TET2 mutations (TET2(mut))
Number of subjects: 783
Study 22430270 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of TET2(mut) and/or IDH(mut)
Number of subjects: 783
Study 20332125 — intervention group
Group type: EXPERIMENTAL
Intervention: Omnitrope 3.3 mg/ml solution
Number of subjects: 36
Study 20332125 — intervention group
Group type: EXPERIMENTAL
Intervention: Omnitrope 6.7 mg/ml solution
Number of subjects: 36
Study 20332125 — intervention group
Group type: COMPARATOR
Intervention: Omnitrope 5 mg/ml powder
Number of subjects: 36
Study 20332125 — intervention group
Group type: COMPARATOR
Intervention: Genotropin 5 mg/ml powder
Number of subjects: 36
Study 20332125 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 36
Study 18990049 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture (deep needling at classic acupuncture points and tender points; n = 7)
Number of subjects: 22
Study 18990049 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (superficial needling at nonacupuncture points; n = 8)
Number of subjects: 22
Study 18990049 — intervention group
Group type: COMPARATOR
Intervention: Control (no needling; n = 7)
Number of subjects: 22
Study 18990049 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 22
Study 18990049 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 22
Study 18990049 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 22
Study 15659145 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 1.5 mg/d
Number of subjects: 634
Study 15659145 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 3.0 mg/d
Number of subjects: 634
Study 15659145 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine
Number of subjects: 634
Study 12617381 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional upper limb physiotherapy (115 minutes, twice per day)
Number of subjects: 4
Study 12617381 — intervention group
Group type: COMPARATOR
Intervention: Wrist extension measurement (twice daily with an electrogoniometer for 3-4 weeks)
Number of subjects: 4
Study 10669898 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac suppository (100 mg)
Number of subjects: 44
Study 10669898 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac injection (75 mg)
Number of subjects: 44
Study 10669898 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations of diclofenac (suppository and injection)
Number of subjects: 44
Study 8933850 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (group I, n = 15)
Number of subjects: 30
Study 8933850 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (group II, n = 15)
Number of subjects: 30
Study 1913092 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplex scanning
Number of subjects: 60
Study 1913092 — intervention group
Group type: EXPERIMENTAL
Intervention: IADSA
Number of subjects: 60
Study 1913092 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplex scanning and IADSA
Number of subjects: 60
Study 1913092 — intervention group
Group type: COMPARATOR
Intervention: IAPM
Number of subjects: 60
Study 7035298 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 18
Study 7035298 — intervention group
Group type: COMPARATOR
Intervention: Neomycin
Number of subjects: 18
Study 30177460 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID as monotherapy
Number of subjects: 3881
Study 30177460 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID as monotherapy
Number of subjects: 3881
Study 30177460 — intervention group
Group type: COMPARATOR
Intervention: Tofacitinib 5 mg BID in combination therapy with csDMARDs
Number of subjects: 3881
Study 30177460 — intervention group
Group type: COMPARATOR
Intervention: Tofacitinib 10 mg BID in combination therapy with csDMARDs
Number of subjects: 3881
Study 26922827 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) for 4 weeks
Number of subjects: 19
Study 26922827 — intervention group
Group type: COMPARATOR
Intervention: Waiting period without intervention (Control) for 4 weeks
Number of subjects: 19
Study 24681658 — intervention group
Group type: EXPERIMENTAL
Intervention: Active skin-surface warming
Number of subjects: 40
Study 24681658 — intervention group
Group type: COMPARATOR
Intervention: Passive insulation
Number of subjects: 40
Study 23243977 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotation/Oscillation power toothbrush (Oral‐B Triumph with SmartGuide)
Number of subjects: 130
Study 23243977 — intervention group
Group type: COMPARATOR
Intervention: Sonic power toothbrush (Sonicare DiamondClean)
Number of subjects: 130
Study 19595327 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine
Number of subjects: 30
Study 19595327 — intervention group
Group type: COMPARATOR
Intervention: Dopamine
Number of subjects: 30
Study 18520610 — intervention group
Group type: EXPERIMENTAL
Intervention: VerifyNow P2Y12 assay
Number of subjects: 68
Study 18520610 — intervention group
Group type: COMPARATOR
Intervention: Thrombin receptor activating peptide-induced platelet aggregation
Number of subjects: 68
Study 16135980 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position on a modified Relton‐Hall spine support
Number of subjects: 30
Study 16135980 — intervention group
Group type: COMPARATOR
Intervention: Knee-chest position on an Andrews‐type table
Number of subjects: 30
Study 11915672 — intervention group
Group type: EXPERIMENTAL
Intervention: Model intervention (involvement of parents and courses for teachers)
Number of subjects: 4215
Study 11915672 — intervention group
Group type: COMPARATOR
Intervention: Control (A)
Number of subjects: 4215
Study 11915672 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (B)
Number of subjects: 4215
Study 11915672 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (C)
Number of subjects: 4215
Study 11915672 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (D)
Number of subjects: 4215
Study 10413264 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 219
Study 10413264 — intervention group
Group type: COMPARATOR
Intervention: Diet
Number of subjects: 219
Study 10413264 — intervention group
Group type: COMPARATOR
Intervention: Diet and Exercise
Number of subjects: 219
Study 10413264 — intervention group
Group type: COMPARATOR
Intervention: No Active Intervention
Number of subjects: 219
Study 7549057 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506
Number of subjects: 121
Study 7549057 — intervention group
Group type: COMPARATOR
Intervention: CsA
Number of subjects: 121
Study 2197345 — intervention group
Group type: EXPERIMENTAL
Intervention: Strain 57-1 (10^5-10^10 CFU)
Number of subjects: 43
Study 2197345 — intervention group
Group type: EXPERIMENTAL
Intervention: Strain C1845 (10^5-10^10 CFU)
Number of subjects: 43
Study 2197345 — intervention group
Group type: COMPARATOR
Intervention: Both strains (10^5-10^10 CFU)
Number of subjects: 43
Study 2197345 — intervention group
Group type: COMPARATOR
Intervention: Both strains (highest doses)
Number of subjects: 43
Study 2197345 — intervention group
Group type: COMPARATOR
Intervention: Both strains
Number of subjects: 43
Study 6992822 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 10
Study 6992822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29299814 — intervention group
Group type: EXPERIMENTAL
Intervention: Community arm (expert lectures in library)
Number of subjects: 111
Study 29299814 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic arm (one-on-one meetings with community health worker)
Number of subjects: 111
Study 27842530 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive multimedia eBook (IME)
Number of subjects: 51
Study 27842530 — intervention group
Group type: COMPARATOR
Intervention: Traditional PowerPoint (TPP)
Number of subjects: 51
Study 24015984 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based smartphone application for self-control training (modified Stroop-task) delivered daily over 4 weeks
Number of subjects: 0
Study 24015984 — intervention group
Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 0
Study 23097968 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.375% with lidocaine 1.0%
Number of subjects: 100
Study 23097968 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% with lidocaine 1.0%
Number of subjects: 100
Study 23097968 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with lidocaine 1.0%
Number of subjects: 100
Study 23097968 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% with lidocaine 1.0%
Number of subjects: 100
Study 20379892 — intervention group
Group type: EXPERIMENTAL
Intervention: Body size perceptions related to health and wealth
Number of subjects: 198
Study 20379892 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived body size preference among Pakistanis in Norway
Number of subjects: 198
Study 20379892 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrepancy score between self-rated body size and perceived body size preference
Number of subjects: 198
Study 18590345 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 0.5 mg/kg/day (neonates)
Number of subjects: 48
Study 18590345 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 1.0 mg/kg/day (neonates)
Number of subjects: 48
Study 18590345 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 1.0 mg/kg/day (infants)
Number of subjects: 48
Study 18590345 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 2.0 mg/kg/day (infants)
Number of subjects: 48
Study 15849809 — intervention group
Group type: EXPERIMENTAL
Intervention: Proglumide treatment group (0.4 g proglumide thrice daily for more than 5 years)
Number of subjects: 301
Study 15849809 — intervention group
Group type: COMPARATOR
Intervention: Control group (operation only)
Number of subjects: 301
Study 12745495 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral transmucosal nicotine (OT‐NIC) lozenge (4 mg)
Number of subjects: 11
Study 12745495 — intervention group
Group type: EXPERIMENTAL
Intervention: OT‐NIC (various flavors)
Number of subjects: 11
Study 12745495 — intervention group
Group type: EXPERIMENTAL
Intervention: OT‐NIC
Number of subjects: 11
Study 11056094 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors or AT1-R antagonists
Number of subjects: 12
Study 11056094 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 12
Study 8647754 — intervention group
Group type: EXPERIMENTAL
Intervention: co-amoxiclav (79 patients)
Number of subjects: 165
Study 8647754 — intervention group
Group type: COMPARATOR
Intervention: phenoxymethyl penicillin (86 patients)
Number of subjects: 165
Study 8647754 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-lactamase activity
Number of subjects: 165
Study 1561294 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive health screening and health education
Number of subjects: 0
Study 4034622 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg methylphenidate hydrochloride (Ritalin)
Number of subjects: 10
Study 4034622 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg methylphenidate hydrochloride (Ritalin)
Number of subjects: 10
Study 4034622 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg methylphenidate hydrochloride (Ritalin)
Number of subjects: 10
Study 4034622 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 30160980 — intervention group
Group type: EXPERIMENTAL
Intervention: Serological biomarkers of collagen formation (PRO-C3)
Number of subjects: 0
Study 30160980 — intervention group
Group type: EXPERIMENTAL
Intervention: Serological biomarkers of collagen degradation (C6M)
Number of subjects: 0
Study 30160980 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of PRO-C5
Number of subjects: 0
Study 30382891 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized dosage of morphine during the procedure when VAS ≥4
Number of subjects: 100
Study 30382891 — intervention group
Group type: COMPARATOR
Intervention: 5 mg of morphine intravenously, followed by 10 mg of morphine subcutaneously 30 min before surgery (Control group)
Number of subjects: 100
Study 26808848 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g of citrulline-malate (CM)
Number of subjects: 10
Study 26808848 — intervention group
Group type: COMPARATOR
Intervention: lemon sugar-free cordial (placebo)
Number of subjects: 10
Study 23861240 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay-for-performance (P4P) incentives
Number of subjects: 0
Study 23861240 — intervention group
Group type: COMPARATOR
Intervention: Control for selection on observables and unobservables
Number of subjects: 0
Study 22458601 — intervention group
Group type: EXPERIMENTAL
Intervention: Hawthorn extract (1000 mg, 1500 mg, and 2500 mg)
Number of subjects: 21
Study 22458601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 20664903 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 80 mg daily
Number of subjects: 101
Study 20664903 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily
Number of subjects: 101
Study 20664903 — intervention group
Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (ASA and clopidogrel)
Number of subjects: 101
Study 17985535 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency electrical stimulation for 1 hour after surgery
Number of subjects: 0
Study 17985535 — intervention group
Group type: COMPARATOR
Intervention: Control group (unstimulated)
Number of subjects: 0
Study 17985535 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency electrical stimulation
Number of subjects: 0
Study 15567543 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee osteoarthritis group (n = 26)
Number of subjects: 66
Study 15567543 — intervention group
Group type: COMPARATOR
Intervention: Age-matched healthy adults (n = 20)
Number of subjects: 66
Study 15567543 — intervention group
Group type: COMPARATOR
Intervention: Young adults (n = 20)
Number of subjects: 66
Study 15567543 — intervention group
Group type: EXPERIMENTAL
Intervention: Biceps femoris to vastus lateralis ratio
Number of subjects: 66
Study 15567543 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG activity of vastus lateralis
Number of subjects: 66
Study 11940275 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-session group intervention
Number of subjects: 360
Study 11940275 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-session group intervention
Number of subjects: 360
Study 11940275 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 360
Study 10463323 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg diazepam
Number of subjects: 12
Study 10463323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8580690 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicinal herbs and chemotherapy on the first postoperational day
Number of subjects: 84
Study 8580690 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment two weeks later (Control)
Number of subjects: 84